OBJECTIVE: This study examined clinical and retention outcomes following variable length prolonged exposure (PE) for posttraumatic stress disorder (PTSD) delivered by one of three treatment modalities (i.e., home-based telehealth [HBT], office-based telehealth [OBT], or in-home-in-person [IHIP]). METHOD: A randomized clinical trial design was used to compare variable-length PE delivered through HBT, OBT, or IHIP. Treatment duration (i.e., number of sessions) was determined by either achievement of a criterion score on the PTSD Checklist for Diagnostic and Statistical Manual-5 (DSM-5; PTSD Checklist for DSM-5) for two consecutive sessions or completion of 15 sessions. Participants received PE via HBT (n = 58), OBT (n = 59) or IHIP (n = 58). Data were collected between 2012 and 2018, and PTSD was diagnosed using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), administered at baseline, posttreatment, and 6 months following treatment completion. The primary clinical outcome was CAPS-5 PTSD severity. Secondary outcomes included self-reported PTSD and depression symptoms, as well as treatment dropout. RESULTS: The clinical effectiveness of PE did not differ by treatment modality across any time point; however, there was a significant difference in treatment dropout. Veterans in the HBT (odds ratio [OR] = 2.67; 95% confidence interval [CI] = 1.10, 6.52; p = .031) and OBT (OR = 5.08; 95% CI = 2.10; 12.26; p < .001) conditions were significantly more likely than veterans in IHIP to drop out of treatment. CONCLUSIONS: Providers can effectively deliver PE through telehealth and in-home, in-person modalities although the rate of treatment completion was higher in IHIP care. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
RCT Entities:
OBJECTIVE: This study examined clinical and retention outcomes following variable length prolonged exposure (PE) for posttraumatic stress disorder (PTSD) delivered by one of three treatment modalities (i.e., home-based telehealth [HBT], office-based telehealth [OBT], or in-home-in-person [IHIP]). METHOD: A randomized clinical trial design was used to compare variable-length PE delivered through HBT, OBT, or IHIP. Treatment duration (i.e., number of sessions) was determined by either achievement of a criterion score on the PTSD Checklist for Diagnostic and Statistical Manual-5 (DSM-5; PTSD Checklist for DSM-5) for two consecutive sessions or completion of 15 sessions. Participants received PE via HBT (n = 58), OBT (n = 59) or IHIP (n = 58). Data were collected between 2012 and 2018, and PTSD was diagnosed using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), administered at baseline, posttreatment, and 6 months following treatment completion. The primary clinical outcome was CAPS-5 PTSD severity. Secondary outcomes included self-reported PTSD and depression symptoms, as well as treatment dropout. RESULTS: The clinical effectiveness of PE did not differ by treatment modality across any time point; however, there was a significant difference in treatment dropout. Veterans in the HBT (odds ratio [OR] = 2.67; 95% confidence interval [CI] = 1.10, 6.52; p = .031) and OBT (OR = 5.08; 95% CI = 2.10; 12.26; p < .001) conditions were significantly more likely than veterans in IHIP to drop out of treatment. CONCLUSIONS: Providers can effectively deliver PE through telehealth and in-home, in-person modalities although the rate of treatment completion was higher in IHIP care. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
Entities:
Keywords:
PTSD; clinical trials; empirical supported treatments; health services; trauma
Authors: Samantha L Connolly; Jennifer L Sullivan; Jan A Lindsay; Stephanie L Shimada; Leonie Heyworth; Kendra R Weaver; Christopher J Miller Journal: Implement Sci Commun Date: 2022-06-20
Authors: Leslie A Morland; Stephanie Y Wells; Lisa H Glassman; Carolyn J Greene; Julia E Hoffman; Craig S Rosen Journal: Curr Treat Options Psychiatry Date: 2020-05-30
Authors: Rebecca K Sripada; Heather M Walters; Dara Ganoczy; Kimberly M Avallone; Jeffrey A Cigrang; Sheila A M Rauch Journal: Adm Policy Ment Health Date: 2022-04-20
Authors: Samantha L Connolly; Kelly L Stolzmann; Leonie Heyworth; Jennifer L Sullivan; Stephanie L Shimada; Kendra R Weaver; Jan A Lindsay; Mark S Bauer; Christopher J Miller Journal: Am Psychol Date: 2021-12-23
Authors: Sarah L Kopelovich; Maria Monroe-DeVita; Benjamin E Buck; Carolyn Brenner; Lorna Moser; L Fredrik Jarskog; Steve Harker; Lydia A Chwastiak Journal: Community Ment Health J Date: 2020-06-19